Professor
University at Buffalo
Dr. Murali Ramanathan is Professor of Pharmaceutical Sciences and Neurology at the University at Buffalo. He received his Ph.D. in Bioengineering from the University of California, San Francisco, CA, M.S., and B.Tech. degrees in Chemical Engineering from Iowa State University, Ames, IA, and the Indian Institute of Technology, Kharagpur, India, respectively.
Dr. Ramanathan research spans the interface between clinical, pharmaceutical, and computational sciences. His multi-disciplinary research spans two inter-related areas: i) quantitative clinical and population pharmacology and, ii) clinical research on the roles of environmental factors in MS progression.
His quantitative clinical pharmacology research focuses on using artificial intelligence and machine learning models to address problems in neurodegenerative diseases and drug development.
His clinical research has focused on multiple sclerosis, a neurological disease that causes physical and cognitive disability, and whose etiology and pathogenesis remain poorly understood. He has made important contributions to understanding the role of environmental factors, particularly lipids in multiple sclerosis disease progression.
Disclosure(s): No financial relationships to disclose
Equity, Data, and Representation in Real-World Clinical Trials and Virtual Populations
Thursday, March 28, 2024
11:00 AM – 12:00 PM MDT